News
 

A pioneering study reveals that an experimental drug that removes amyloid plaques from the brain can reduce the risk of developing dementia by up to 50% in people with genetic predisposition to Alzheimer's.

A new study reveals that blood vessels in the retina may show early signs of dementia and Alzheimer's risk.

A new study reveals that people whose biological age is greater than their chronological age might be more likely to develop dementia.

Summary: A recent study demonstrates that exercise significantly improves the effectiveness of neuron transplants derived from stem cells in Parkinson's disease models.

Researchers at the University of Florida have developed an AI-driven software that significantly enhances the diagnosis of Parkinson's disease and related disorders. The system, named AIDP (Automated Imaging Differentiation for Parkinsonism), employs MRI scans and machine learning algorithms to identify patterns of neurodegeneration, achieving...

An international study led by Washington University in St. Louis has found that an experimental anti-amyloid drug can reduce the risk of developing dementia by 50% in individuals with genetic mutations that predispose them to early-onset Alzheimer's. In a subgroup of participants who began treatment symptom-free and continued it for eight years, a...

A recent study published in JAMA Network Open investigated the relationship between cardiovascular risk and migraine activity in Dutch men and women. Using the SCORE2 system, which evaluates the risk of cardiovascular diseases, the researchers analyzed whether cardiovascular health influenced migraine patterns.

Scientists are exploring new treatments for Multiple Sclerosis (MS) that target the immune system more precisely. Current therapies reduce attacks on nerve cells but also weaken the body's defenses.

A new study published in JAMA Network Open reveals that hearing loss in middle-aged and older adults is linked to cognitive impairment.

Researchers at the University of Wisconsin–Madison are using artificial intelligence (AI) to tackle one of the deadliest forms of brain cancer: glioblastoma.